IBI
Istituto Biochimico Italiano G. Lorenzini S.p.A. is an independent Italian
research-based pharmaceutical company pioneer since 1918 in the development,
production and marketing of medicines worldwide.
Following
our mission of “creating to contribute”, we have used innovative technology to
develop a portfolio of products to improve the health of patients.
IBI is
present has an established leadership in penicillin market and capability of
aseptic filling for injectable drug products aimed for different therapeutic
areas.
IBI’s
high quality standards is internationally recognized by the most demanding
health authorities : AIFA, US FDA, EDQM, TGA and PMDA.
R&D is one of the strengths of the Istituto Biochimico Italiano. Thanks to the fact that many manufacturing processes have been developed entirely in house; from the semi synthesis of active substances (ß-lactam) to the development of the formulations, the company has obtained numerous patents. Investment in resources and in innovative equipment enables us to continuously improve producti...
IT